Board of Directors

PIA-PR 2017-2018 Board of Directors

The PIA-PR Board of Directors is composed of eleven members, represented by a top executive in Puerto Rico. Five of these members represent the manufacturing sector and six represent the commercial sector. In addition, there are three ex-officio members: the PIA-PR Operations Vice President, PIA-PR Legal Counselor, and PIA-PR Advisor to the Board

PIA-PR gathers and represents research-based multinational pharmaceutical and biotechnology companies with operations on the island. These are 13 corporations organized in 21 manufacturing operations with 13 commercial entities. The biopharmaceutical industry represents 26.5% of the island's Gross Domestic Product 60% of all island imports and 98% of all island exports. The biopharmaceutical industry in Puerto Rico generates over 78,000 jobs on the island: 18,000 direct and 60,000 indirect.



 Wendy Perry

 Managing Director   

 Merck Commercial Operations





  Ileana Quiñónes 

  VP & GM

  IPR Pharmaceuticals (AstraZeneca)





 Elsa Saavedra 

 General Manager

 AstraZeneca (Commercial)





 David L. Thompson

 General Manager

 AbbVie (Manufacturing)





 Andrew Willy 

 General Manager 

 Amgen (Commercial) 


 Jorge López

 VP & General Manager 

 Bristol Myers Squibb (Manufacturing)




Victor Cruz

 VP & General Manager 

 Lilly (Manufacturing)


 Brenda Torres 

 VP Drug Products                

 Amgen (Manufacturing)



 José Viera 

 General Manager 

 Allergan (Commercial)





Board Members


Rafael Castro   

VP Operations






Eduardo M. Negrón-Navas   

Legal Counsel 

Eduardo Negrón Law


Iván Román   

Advisor to the Board

Stratech, LLC